HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Poynard Selected Research

gemcitabine-oxaliplatin regimen

6/2008Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.
4/2007Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Poynard Research Topics

Disease

95Fibrosis (Cirrhosis)
08/2021 - 02/2002
45Chronic Hepatitis C
01/2019 - 03/2002
44Liver Cirrhosis (Hepatic Cirrhosis)
03/2022 - 05/2002
32Infections
01/2022 - 03/2002
27Liver Diseases (Liver Disease)
10/2020 - 12/2002
18Non-alcoholic Fatty Liver Disease
03/2022 - 12/2005
15Chronic Hepatitis B
01/2015 - 08/2003
13Hepatitis C
08/2020 - 05/2002
12Hepatocellular Carcinoma (Hepatoma)
08/2021 - 12/2003
9Hepatitis
01/2020 - 01/2006
8Inflammation (Inflammations)
03/2022 - 03/2002
8Hepatitis B
12/2019 - 02/2004
8Alcoholic Liver Diseases (Alcoholic Liver Disease)
11/2018 - 12/2002
7Coinfection
11/2016 - 03/2003
6Insulin Resistance
08/2020 - 02/2004
6Fatty Liver
01/2020 - 12/2005
6Vasculitis (Vasculitides)
01/2019 - 07/2006
5Type 2 Diabetes Mellitus (MODY)
03/2022 - 07/2008
5Necrosis
01/2019 - 02/2002
5Cryoglobulinemia
01/2019 - 11/2004
4Liver Neoplasms (Liver Cancer)
08/2021 - 12/2003
4Alcoholic Fatty Liver
01/2020 - 09/2007
4Disease Progression
12/2019 - 04/2007
4Chemical and Drug Induced Liver Injury
01/2019 - 08/2011
4Chronic Hepatitis (Chronic Active Hepatitis)
01/2018 - 01/2005
3Obesity
03/2022 - 05/2007
3Neoplasms (Cancer)
02/2010 - 02/2006
3Alcoholic Hepatitis
04/2003 - 03/2002
2COVID-19
03/2022 - 01/2020
2End Stage Liver Disease
01/2019 - 12/2016
2Ascites
10/2018 - 06/2010
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2016 - 12/2003
2Hypertension (High Blood Pressure)
01/2016 - 05/2015
2Overweight
05/2015 - 12/2003
2Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
04/2015 - 02/2009
2Hemorrhage
02/2013 - 01/2010
2Systemic Vasculitis
11/2012 - 07/2006
2HIV Infections (HIV Infection)
10/2011 - 02/2009
2Portal Hypertension
06/2011 - 12/2007
2Shock
06/2010 - 12/2007
2Liver Failure
01/2006 - 12/2002
2Hepatorenal Syndrome
04/2002 - 02/2002

Drug/Important Bio-Agent (IBA)

66Biomarkers (Surrogate Marker)IBA
01/2020 - 09/2002
21Ribavirin (Virazole)FDA LinkGeneric
01/2018 - 03/2002
19InterferonsIBA
01/2019 - 03/2002
17Antiviral Agents (Antivirals)IBA
08/2021 - 10/2002
11HaptoglobinsIBA
03/2022 - 01/2003
11Alanine Transaminase (SGPT)IBA
04/2015 - 03/2002
10Lamivudine (Epivir)FDA Link
11/2010 - 12/2003
8Transaminases (Aminotransferases)IBA
01/2020 - 08/2003
8BilirubinIBA
01/2019 - 01/2003
8RNA (Ribonucleic Acid)IBA
02/2013 - 03/2002
8Interferon-alpha (Interferon Alfa)IBA
06/2011 - 01/2004
6Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2022 - 01/2003
6peginterferon alfa-2b (Pegintron)FDA Link
03/2013 - 05/2002
5Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2007
5gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2009 - 01/2003
4Glucose (Dextrose)FDA LinkGeneric
08/2020 - 12/2003
4SofosbuvirIBA
01/2018 - 10/2016
4Pharmaceutical PreparationsIBA
01/2017 - 07/2011
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2014 - 01/2008
4adefovir dipivoxil (Hepsera)FDA Link
01/2008 - 12/2003
4Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
10/2007 - 01/2003
3Insulin (Novolin)FDA Link
08/2020 - 07/2008
3Hepatitis B e AntigensIBA
12/2019 - 08/2005
3CreatinineIBA
10/2018 - 04/2002
3CryoglobulinsIBA
01/2017 - 06/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 04/2002
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2015 - 03/2006
3Protease Inhibitors (Protease Inhibitor)IBA
07/2014 - 02/2009
3Dihydrotachysterol (AT 10)IBA
04/2014 - 02/2004
3adefovirIBA
11/2010 - 01/2005
3NucleosidesIBA
11/2010 - 12/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 12/2002
3Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2008 - 12/2003
3GemcitabineFDA Link
06/2008 - 12/2003
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2021 - 10/2020
2TransferasesIBA
08/2021 - 06/2006
2HDL CholesterolIBA
01/2020 - 06/2010
2Triglycerides (Triacylglycerol)IBA
01/2019 - 07/2003
2InterleukinsIBA
01/2017 - 07/2010
2AntibodiesIBA
01/2015 - 03/2006
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
07/2014 - 09/2012
2Vitamin DFDA LinkGeneric
11/2012 - 10/2011
2hydroxide ionIBA
11/2012 - 10/2011
2nasIBA
01/2012 - 02/2010
2AntigensIBA
06/2011 - 12/2006
2carbohydrate-deficient transferrinIBA
04/2010 - 01/2009
2Rosiglitazone (Avandia)FDA Link
02/2010 - 07/2008
2TelbivudineFDA Link
07/2009 - 08/2005
2Interferon alpha-2 (Roferon-A)FDA Link
07/2003 - 03/2002
2TerlipressinIBA
04/2002 - 02/2002
1Blood Proteins (Serum Proteins)IBA
03/2022
1LectinsIBA
10/2020
1acarboxyprothrombin (PIVKA)IBA
10/2020
1Polysaccharides (Glycans)IBA
10/2020

Therapy/Procedure

36Therapeutics
12/2019 - 03/2002
7Liver Transplantation
12/2016 - 02/2002
4Aftercare (After-Treatment)
10/2013 - 05/2002
2gemcitabine-oxaliplatin regimen
06/2008 - 04/2007